COR Quote, Financials, Valuation and Earnings

WEED, Inc. has a net margin of 0.66% compared to Cencora, Inc.'s net margin of --. Cencora, Inc.'s return on equity of 107.99% beat WEED, Inc.'s return on equity of --.

Cencora, Inc. has a consensus price target of $403.79, signalling upside risk potential of 11.83%. On the other hand WEED, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Cencora, Inc. has higher upside potential than WEED, Inc., analysts believe Cencora, Inc. is more attractive than WEED, Inc..

Cencora, Inc. has a beta of 0.676, which suggesting that the stock is 32.374% less volatile than S&P 500. In comparison WEED, Inc. has a beta of 0.856, suggesting its less volatile than the S&P 500 by 14.38%.

Cencora, Inc. has a quarterly dividend of $0.60 per share corresponding to a yield of 0.64%. WEED, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cencora, Inc. pays 27.63% of its earnings as a dividend. WEED, Inc. pays out -- of its earnings as a dividend. Cencora, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Cencora, Inc. quarterly revenues are $85.9B, which are larger than WEED, Inc. quarterly revenues of --. Cencora, Inc.'s net income of $566.1M is higher than WEED, Inc.'s net income of -$73.9K. Notably, Cencora, Inc.'s price-to-earnings ratio is 43.43x while WEED, Inc.'s PE ratio is 180.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cencora, Inc. is 0.22x versus -- for WEED, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Cardinal Health, Inc. has a net margin of 0.66% compared to Cencora, Inc.'s net margin of 0.72%. Cencora, Inc.'s return on equity of 107.99% beat Cardinal Health, Inc.'s return on equity of --.

Cencora, Inc. has a consensus price target of $403.79, signalling upside risk potential of 11.83%. On the other hand Cardinal Health, Inc. has an analysts' consensus of $247.80 which suggests that it could grow by 10.41%. Given that Cencora, Inc. has higher upside potential than Cardinal Health, Inc., analysts believe Cencora, Inc. is more attractive than Cardinal Health, Inc..

Cencora, Inc. has a beta of 0.676, which suggesting that the stock is 32.374% less volatile than S&P 500. In comparison Cardinal Health, Inc. has a beta of 0.642, suggesting its less volatile than the S&P 500 by 35.798%.

Cencora, Inc. has a quarterly dividend of $0.60 per share corresponding to a yield of 0.64%. Cardinal Health, Inc. offers a yield of 0.91% to investors and pays a quarterly dividend of $0.51 per share. Cencora, Inc. pays 27.63% of its earnings as a dividend. Cardinal Health, Inc. pays out 31.43% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Cencora, Inc. quarterly revenues are $85.9B, which are larger than Cardinal Health, Inc. quarterly revenues of $65.6B. Cencora, Inc.'s net income of $566.1M is higher than Cardinal Health, Inc.'s net income of $471M. Notably, Cencora, Inc.'s price-to-earnings ratio is 43.43x while Cardinal Health, Inc.'s PE ratio is 32.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cencora, Inc. is 0.22x versus 0.22x for Cardinal Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

McKesson Corp. has a net margin of 0.66% compared to Cencora, Inc.'s net margin of 1.18%. Cencora, Inc.'s return on equity of 107.99% beat McKesson Corp.'s return on equity of --.

Cencora, Inc. has a consensus price target of $403.79, signalling upside risk potential of 11.83%. On the other hand McKesson Corp. has an analysts' consensus of $980.40 which suggests that it could grow by 3.48%. Given that Cencora, Inc. has higher upside potential than McKesson Corp., analysts believe Cencora, Inc. is more attractive than McKesson Corp..

Cencora, Inc. has a beta of 0.676, which suggesting that the stock is 32.374% less volatile than S&P 500. In comparison McKesson Corp. has a beta of 0.405, suggesting its less volatile than the S&P 500 by 59.521%.

Cencora, Inc. has a quarterly dividend of $0.60 per share corresponding to a yield of 0.64%. McKesson Corp. offers a yield of 0.32% to investors and pays a quarterly dividend of $0.82 per share. Cencora, Inc. pays 27.63% of its earnings as a dividend. McKesson Corp. pays out 10.69% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Cencora, Inc. quarterly revenues are $85.9B, which are smaller than McKesson Corp. quarterly revenues of $106.2B. Cencora, Inc.'s net income of $566.1M is lower than McKesson Corp.'s net income of $1.3B. Notably, Cencora, Inc.'s price-to-earnings ratio is 43.43x while McKesson Corp.'s PE ratio is 27.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cencora, Inc. is 0.22x versus 0.30x for McKesson Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Pineapple, Inc. has a net margin of 0.66% compared to Cencora, Inc.'s net margin of -184.62%. Cencora, Inc.'s return on equity of 107.99% beat Pineapple, Inc.'s return on equity of --.

Cencora, Inc. has a consensus price target of $403.79, signalling upside risk potential of 11.83%. On the other hand Pineapple, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Cencora, Inc. has higher upside potential than Pineapple, Inc., analysts believe Cencora, Inc. is more attractive than Pineapple, Inc..

Cencora, Inc. has a beta of 0.676, which suggesting that the stock is 32.374% less volatile than S&P 500. In comparison Pineapple, Inc. has a beta of 41.097, suggesting its more volatile than the S&P 500 by 4009.732%.

Cencora, Inc. has a quarterly dividend of $0.60 per share corresponding to a yield of 0.64%. Pineapple, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cencora, Inc. pays 27.63% of its earnings as a dividend. Pineapple, Inc. pays out -- of its earnings as a dividend. Cencora, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Cencora, Inc. quarterly revenues are $85.9B, which are larger than Pineapple, Inc. quarterly revenues of $1.3K. Cencora, Inc.'s net income of $566.1M is higher than Pineapple, Inc.'s net income of -$2.4K. Notably, Cencora, Inc.'s price-to-earnings ratio is 43.43x while Pineapple, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cencora, Inc. is 0.22x versus 50.83x for Pineapple, Inc.. Usually stocks with elevated PS ratios are considered overvalued.